Astronaut's organ doses inferred from measurements in a human phantom outside the international space station.

Space radiation hazards are recognized as a key concern for human space flight. For long-term interplanetary missions, they constitute a potentially limiting factor since current protection limits for low-Earth orbit missions may be approached or even exceeded. In such a situation, an accurate risk assessment requires knowledge of equivalent doses in critical radiosensitive organs rather than only skin doses or ambient doses from area monitoring. To achieve this, the MATROSHKA experiment uses a human phantom torso equipped with dedicated detector systems. We measured for the first time the doses from the diverse components of ionizing space radiation at the surface and at different locations inside the phantom positioned outside the International Space Station, thereby simulating an extravehicular activity of an astronaut. The relationships between the skin and organ absorbed doses obtained in such an exposure show a steep gradient between the doses in the uppermost layer of the skin and the deep organs with a ratio close to 20. This decrease due to the body self-shielding and a concomitant increase of the radiation quality factor by 1.7 highlight the complexities of an adequate dosimetry of space radiation. The depth-dose distributions established by MATROSHKA serve as benchmarks for space radiation models and radiation transport calculations that are needed for mission planning.

Dose equivalents inside the MIR Space Station measured by the combination of CR-39 plates and TLDs and their comparison with those on Space Shuttle STS-79, -84 and -91 missions.

In 1997, four dosimeter packages, each of which contains two CR-39 plates and 18 TLDs (Mg2SiO4:Tb), were placed inside the MIR Space Station and flew on an orbit with an inclination angle of 51.6 degrees and an altitude of approximately 400 km for 40 days. We estimated the absorbed doses, dose equivalents and effective quality factors during the flight by combining CR-39 data and TLD data. We then compared these results to those obtained with the same analysis method from the dosimeter packages on board Space Shuttle missions STS-79, -84 and -91 that flew along the same orbit. Finally, the differences between our results and those obtained by another group using passive dosimeters on the MIR are discussed.